scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.272.3.1433 |
P698 | PubMed publication ID | 8999808 |
P2093 | author name string | S L Hazen | |
J W Heinecke | |||
U P Steinbrecher | |||
S Oh-ishi | |||
P Wagner | |||
C Leeuwenburgh | |||
M M Hardy | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nitrogen | Q627 |
P304 | page(s) | 1433-1436 | |
P577 | publication date | 1997-01-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima | |
P478 | volume | 272 |
Q35873677 | 17beta-Estradiol reverses shear-stress-mediated low density lipoprotein modifications |
Q37366288 | 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima |
Q34616416 | Absence of an effect of vitamin E on protein and lipid radical formation during lipoperoxidation of LDL by lipoxygenase |
Q36906145 | Activation and silencing of matrix metalloproteinases |
Q34488343 | Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle |
Q31060150 | Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells |
Q73224129 | Alpha- and beta-carotenes in low density lipoprotein are the preferred target for nitric oxide-induced oxidation |
Q46441616 | Analysis of aromatic nitration, chlorination, and hydroxylation by gas chromatography-mass spectrometry |
Q30988457 | Analysis of peptides and proteins containing nitrotyrosine by matrix-assisted laser desorption/ionization mass spectrometry |
Q78659305 | Antioxidant and diffusion properties of nitric oxide in low-density lipoprotein |
Q37286296 | Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease |
Q28392966 | Asbestos inhalation induces reactive nitrogen species and nitrotyrosine formation in the lungs and pleura of the rat |
Q37364334 | Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease |
Q37172222 | Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites |
Q33649712 | Atherosclerosis: A Link Between Lipid Intake and Protein Tyrosine Nitration |
Q92782717 | Binding of myeloperoxidase to the extracellular matrix of smooth muscle cells and subsequent matrix modification |
Q35134291 | Biological selectivity and functional aspects of protein tyrosine nitration |
Q34006311 | Cell signaling by reactive nitrogen and oxygen species in atherosclerosis |
Q32062976 | Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36. |
Q36967764 | Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease |
Q58762763 | Chlorination and oxidation of human plasma fibronectin by myeloperoxidase-derived oxidants, and its consequences for smooth muscle cell function |
Q44529103 | Coenzyme Q(10) supplementation inhibits aortic lipid oxidation but fails to attenuate intimal thickening in balloon-injured New Zealand white rabbits. |
Q36401387 | Complementary roles for scavenger receptor A and CD36 of human monocyte-derived macrophages in adhesion to surfaces coated with oxidized low-density lipoproteins and in secretion of H2O2. |
Q77161290 | Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis |
Q77907848 | Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues |
Q59164772 | Different roles for nitrogen monoxide and peroxynitrite in lipid peroxidation induced by activated neutrophils |
Q36005247 | Diffusion of peroxynitrite across erythrocyte membranes |
Q35747306 | Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis |
Q77135038 | Effects of peroxynitrite on plasma components of the reverse cholesterol transport pathway |
Q28344995 | Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions |
Q24311407 | Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers |
Q44632355 | Evaluation of the antioxidant response in the plasma of healthy or hypertensive subjects after short-term exercise. |
Q42991232 | Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque |
Q42482363 | Expression of superoxide dismutase messenger RNA in adult rat brain cholinergic neurons |
Q41154240 | Factors Associated with Nitric Oxide-mediated β2 Integrin Inhibition of Neutrophils |
Q46176653 | Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships |
Q90341513 | Flavonoids Ability to Disrupt Inflammation Mediated by Lipid and Cholesterol Oxidation |
Q30719745 | Fluctuation of serum NO(x) concentration at stroke onset in a rat spontaneous stroke model (M-SHRSP). Peroxynitrite formation in brain lesions |
Q42528104 | Gamma-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation |
Q44248756 | Gas chromatography/mass spectrometry assay for 3-nitrotyrosine |
Q36922288 | Hemodynamics influences vascular peroxynitrite formation: Implication for low-density lipoprotein apo-B-100 nitration |
Q33817228 | High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences |
Q53235465 | How urine analysis reflects oxidative stress--nitrotyrosine as a potential marker. |
Q46807211 | Hydrophobic tyrosyl probes for monitoring nitration reactions in membranes |
Q73103541 | Hypochlorite modified LDL are a stronger agonist for platelets than copper oxidized LDL |
Q43812531 | Immunodetection of 3-nitrotyrosine in the liver of zymosan-treated rats with a new monoclonal antibody: comparison to analysis by HPLC. |
Q28350068 | Increased atherosclerosis in myeloperoxidase-deficient mice |
Q35140371 | Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression |
Q35070737 | Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production |
Q36083498 | Inflammation and NO(X)-induced nitration: assay for 3-nitrotyrosine by HPLC with electrochemical detection |
Q52721996 | Inflammation in sickle cell disease. |
Q35739814 | Inflammatory and oxidative markers in atherosclerosis: relationship to outcome |
Q37142322 | Influence of intramolecular electron transfer mechanism in biological nitration, nitrosation, and oxidation of redox-sensitive amino acids |
Q27021840 | Inorganic nitrite supplementation for healthy arterial aging |
Q81802750 | LDL protein nitration: implication for LDL protein unfolding |
Q40958378 | Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages |
Q30912339 | Lipoic acid reduces ischemia-reperfusion injury in animal models |
Q45125520 | Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: an intracellular study |
Q22253929 | Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species |
Q33922502 | Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage |
Q33864171 | Measurement of 3-nitrotyrosine and 5-nitro-gamma-tocopherol by high-performance liquid chromatography with electrochemical detection |
Q44248744 | Measurement of protein nitration and S-nitrosothiol formation in biology and medicine |
Q73191375 | Mechanism for the peroxynitrite scavenging activity by anthocyanins |
Q77907835 | Modification of proteins and lipids by myeloperoxidase |
Q34006317 | Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis |
Q73378050 | Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis |
Q52629638 | Myeloperoxidase derived oxidants damage artery wall proteins in an animal model of chronic kidney disease accelerated atherosclerosis. |
Q34791672 | Myeloperoxidase produces nitrating oxidants in vivo |
Q34006268 | Myeloperoxidase-generated oxidants and atherosclerosis |
Q33852491 | Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro |
Q57791197 | Nitric oxide and hypercholesterolemia: a matter of oxidation and reduction? |
Q24645400 | Nitric oxide and peroxynitrite in health and disease |
Q37735480 | Nitric oxide signaling in vascular biology |
Q78099814 | Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide-nitrite system promotes lipid peroxidation of low density lipoprotein |
Q77718601 | Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis |
Q36363578 | Oxidative Stress Alters the Morphology and Toxicity of Aortic Medial Amyloid |
Q37318786 | Oxidative modification of LDL: its pathological role in atherosclerosis |
Q33554184 | Oxidative risk for atherothrombotic cardiovascular disease |
Q35088524 | Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis |
Q34658022 | Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress |
Q41891957 | Oxidized lipid accumulates in the presence of alpha-tocopherol in atherosclerosis. |
Q77601534 | Oxidized phospholipids as a new landmark in atherosclerosis |
Q45711483 | Participation of peroxynitrite in oxidative modification of LDL by aqueous extracts of cigarette smoke |
Q33610044 | Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules |
Q34310277 | Pathophysiology of oxidative stress in diabetes mellitus |
Q73343406 | Peroxynitrite formation by diesel exhaust particles in alveolar cells: Links to pulmonary inflammation |
Q33943403 | Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains |
Q34405070 | Plant-derived phenolics inhibit the accrual of structurally characterised protein and lipid oxidative modifications |
Q37137106 | Potential Benefits of Peroxynitrite |
Q27021668 | Protein Oxidation in Aging: Does It Play a Role in Aging Progression? |
Q73837561 | Quantification of 3-nitrotyrosine in biological tissues and fluids: generating valid results by eliminating artifactual formation |
Q46807219 | Quantification of 3-nitrotyrosine levels using a benchtop ion trap mass spectrometry method |
Q45980704 | Quantitation of protein-bound 3-nitrotyrosine by high-performance liquid chromatography with electrochemical detection. |
Q35173711 | Quantitative analysis of amino Acid oxidation markers by tandem mass spectrometry |
Q28383441 | Reactive nitrogen species in cellular signaling |
Q43079029 | Recombinant heat shock protein 27 (HSP27/HSPB1) protects against cadmium-induced oxidative stress and toxicity in human cervical cancer cells. |
Q36681658 | Reprint of "oxidative alterations of cyclooxygenase during atherogenesis" [Prostag. Oth. Lipid. M. 80 (2006) 1-14]. |
Q36264817 | Risk factors for coronary heart disease in type II diabetes mellitus |
Q41937076 | Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins |
Q41871080 | Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. |
Q37281608 | Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. |
Q34809253 | Signal transduction by protein tyrosine nitration: competition or cooperation with tyrosine phosphorylation-dependent signaling events? |
Q44307988 | Simultaneous determination of methionine sulfoxide and methionine in blood plasma using gas chromatography-mass spectrometry |
Q35791924 | Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities |
Q35933304 | Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease |
Q35024665 | The Dynamics of Oxidized LDL during Atherogenesis |
Q26786137 | The balance of powers: Redox regulation of fibrogenic pathways in kidney injury |
Q33867851 | The effect of neighboring methionine residue on tyrosine nitration and oxidation in peptides treated with MPO, H2O2, and NO2(-) or peroxynitrite and bicarbonate: role of intramolecular electron transfer mechanism? |
Q31886442 | The effect of pharmacological doses of different antioxidants on oxidation parameters and atherogenesis in hyperlipidaemic rabbits |
Q36795230 | The interactions of oxidative stress and inflammation with vascular dysfunction in ageing: the vascular health triad |
Q41628567 | The interplay of nitric oxide and peroxynitrite with signal transduction pathways: implications for disease |
Q44575005 | The inversely proportional relation between nitric oxide and lipid peroxidation in atherosclerotic plaque formation in human |
Q36401988 | The role of tobacco smoke induced mitochondrial damage in vascular dysfunction and atherosclerosis. |
Q30240734 | The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture. |
Q40617645 | The state of macrophage differentiation determines the TNFα response to nitrated lipoprotein uptake |
Q37012131 | Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation |
Q37142318 | Using tandem mass spectrometry to quantify site-specific chlorination and nitration of proteins: model system studies with high-density lipoprotein oxidized by myeloperoxidase. |
Q37133914 | Vascular system: role of nitric oxide in cardiovascular diseases |
Q73626435 | What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? |
Q57943221 | [35] Assessment of peroxynitrite scavengers in Vitro |
Q63676967 | [47] Nitration of unsaturated fatty acids by nitric oxide-derived reactive species |
Q80022679 | gamma-tocopherol, but not alpha-tocopherol, potently inhibits neointimal formation induced by vascular injury in insulin resistant rats |
Search more.